AAT BIOQUEST INC

AAT BIOQUEST, INC. specializes in biotechnology research and development, focusing on the design, synthesis, and application of advanced biochemical reagents and assay technologies for life science and public health applications. Their technical expertise includes molecular diagnostics, fluorescent probe development, cell-based assay systems, and high-throughput screening platforms, enabling precise detection and quantification of biological targets in complex samples. The company differentiates itself through proprietary chemistries tailored for sensitivity and specificity in research and diagnostic workflows, supporting applications in infectious disease, immunology, and cellular signaling studies. Their solutions are engineered for compatibility with automated platforms and regulatory-compliant environments, serving as critical tools for laboratories engaged in translational research. AAT BIOQUEST has demonstrated engagement with the Department of Health and Human Services, delivering R&D services that advance public health biotechnology initiatives. Their work supports HHS mission-critical objectives in infectious disease surveillance, diagnostic innovation, and biomedical tool development, establishing a focused partnership centered on accelerating scientific discovery through robust, reproducible bioanalytical methods. The contractor’s primary industry focus is in biotechnology research and development, specifically within the 541714 NAICS category, which encompasses non-nanobiotech innovation in molecular biology, bioconjugation, and diagnostic assay design. This positions them as a niche supplier of specialized reagents and assay technologies to government-funded research institutions and public health laboratories seeking validated, scalable biological tools. AAT BIOQUEST, INC. is a Women-Owned Small Business headquartered in Pleasanton, California, with a structure aligned to federal small business criteria. Their WOSB certification underscores their commitment to diversity in federal contracting and enhances their eligibility for targeted set-aside programs. The company operates with a lean, specialized team focused on R&D execution and product development for government and academic partners.